You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Horse anti-thymocyte globulin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

Recruiting
  • Aplastic Anemia
  • +3 more
  • Anti-Thymocyte Globulin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)

Active, not recruiting
  • Severe Aplastic Anemia
  • Los Angeles, California
  • +12 more
Feb 10, 2022

Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome Trial in Houston (BL-8040, horse anti-thymocyte globulin (hATG),

Completed
  • Aplastic Anemia
  • Hypoplastic Myelodysplastic Syndrome
  • Houston, Texas
    MD Anderson Cancer Center
Dec 28, 2020

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • (no location specified)
Oct 29, 2023

Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))

Completed
Has Results
  • Inherited Immune Deficiencies
  • Campath 1H
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

Not yet recruiting
  • Renal Transplant Rejection
  • Induction Therapy
  • (no location specified)
Sep 22, 2022

Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy Trial in United States (High-dose methylprednisolone,

Recruiting
  • Acute Liver Failure
  • +4 more
  • High-dose methylprednisolone
  • +6 more
  • Los Angeles, California
  • +19 more
Dec 5, 2022

Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

Recruiting
  • Living Donor Kidney Transplantation
  • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
  • Palo Alto, California
  • +1 more
May 6, 2022

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Diabetes, Type 1 Trial in Worldwide (Anti-Human Thymocyte Immunoglobulin, Rabbit)

Recruiting
  • Diabetes Mellitus, Type 1
  • Anti-Human Thymocyte Immunoglobulin, Rabbit
  • Graz, Austria
  • +14 more
Feb 23, 2022

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte

Recruiting
  • Acute Leukemia
  • +2 more
  • Darlinghurst, New South Wales, Australia
  • +8 more
Aug 30, 2021

Graves Orbitopathy Trial in Katowice (rabbit anti-thymocyte globulin)

Recruiting
  • Graves Orbitopathy
  • rabbit anti-thymocyte globulin
  • Katowice, Silesia, Poland
    Department of Internal Medicine and Oncological Chemotherapy, Me
Jan 14, 2022

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Personalized rATG (P-rATG)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 31, 2022

Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancy
  • Bone Marrow Transplant
  • New York, New York
    Weill Cornell Medical College
Oct 27, 2021